Describe the variants and ligands
Paste the TP53 variants to target and the ligand pools to screen.
All platforms
Therapeutics / TP53-Associated drug discovery platform
Find small molecules that target mutant TP53.
Paste TP53 variants and candidate ligands — from literature, your own compounds, or known drugs — then run the pipeline to dock, prescreen and rank candidates for mutant-selective rescue of p53 function.
Use your existing Wellmatix account. Platform access is subject to approval.
TP53-Associated drug discovery platformWorkflow overview
TP53 variantsMolecular dockingDrug repurposing
01Describe the variants and ligands
02Run the docking pipeline
03Review the ranking
HOW IT WORKS
A focused path through your research.
From your inputs to evidence you can review.
Run the docking pipeline
Submit the job and follow the prepare, assemble, simulate and rank stages.
Review the ranking
Inspect mutant-selectivity, ADMET and evidence scores before experimental validation.
BEFORE YOU BEGIN
Bring your research context.
Prepare the information relevant to your workflow. The platform guides you through the required fields.
- TP53 variant list (e.g. V157F, R175H)
- Candidate ligands (SMILES) from literature, in-house, or repurposing pools
- Generative design and report toggles
WHAT YOU CAN EXPLORE
Outputs for your next decision.
- Ranked small-molecule candidates
- Mutant vs wild-type selectivity scores
- Executive report and downloadable results
Available outputs depend on the selected workflow and completed stages. Computational findings support expert review and experimental validation.
YOUR NEXT RESEARCH QUESTION
Explore TP53-Associated drug discovery platform.
Sign in, request access if needed, and continue in your workspace.